Colorado Code § 18-18-206

Schedule IV - repeal
Open in Lexace · Ask the AI about this section
(1) A substance shall be added to schedule IV by the
general assembly when:
(a) The substance has a low potential for abuse relative to substances included in
schedule III;
(b) The substance has currently accepted medical use in treatment in the United States;
and
(c) The abuse of the substance may lead to limited physical dependence or psychological
dependence relative to the substances included in schedule III.
(2) Unless specifically excepted by Colorado or federal law or Colorado or federal
regulation or more specifically included in another schedule, the following controlled substances
are listed in schedule IV:
(a) Any material, compound, mixture, isomers or salts or isomers, or preparation
containing any of the following narcotic drugs, or their salts calculated as the free anhydrous
base or alkaloid, in limited quantities as follows:
(I) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine
sulfate per dosage unit;
(II) Propoxyphene (dosage forms);
(III) Butorphanol;
(b) Any material, compound, mixture, or preparation containing any quantity of the
following substances having a depressant effect on the central nervous system, including any
salts, isomers, and salts of isomers of them that are theoretically possible within the specific
chemical designation:
(I) Alprazolam;
(II) Barbital;
(III) Bromazepam;
(IV) Camazepam;
(V) Chloral betaine;
(VI) Chloral hydrate;
(VII) Chlordiazepoxide;
(VIII) Clobazam;
(IX) Clonazepam;
(X) Clorazepate;
(XI) Clotiazepam;
(XII) Cloxazolam;
(XIII) Delorazepam;
(XIV) Diazepam;
(XV) Estazolam;
(XVI) Ethchlorvynol;
(XVII) Ethinamate;
(XVIII) Ethyl loflazepate;
(XIX) Fludiazepam;
(XX) Flunitrazepam;
(XXI) Flurazepam;
(XXII) Halazepam;
(XXIII) Haloxazolam;
(XXIV) Ketazolam;
(XXV) Loprazolam;
(XXVI) Lorazepam;
(XXVII) Lormetazepam;
(XXVIII) Mebutamate;
(XXIX) Medazepam;
(XXX) Meprobamate;
(XXXI) Methohexital;
(XXXII) Methylphenobarbital (mephobarbital);
(XXXIII) Midazolam;
(XXXIV) Nimetazepam;
(XXXV) Nitrazepam;
(XXXVI) Nordiazepam;
(XXXVII) Oxazepam;
(XXXVIII) Oxazolam;
(XXXIX) Paraldehyde;
(XL) Petrichloral;
(XLI) Phenobarbital;
(XLII) Pinazepam;
(XLIII) Prazepam;
(XLIV) Quazepam;
(XLV) Temazepam;
(XLVI) Tetrazepam;
(XLVII) Triazolam;
(XLVIII) Zolpidem;
(c) (I) Any material, compound, mixture, or preparation containing any quantity of the
following substance, including any salts, isomers of it that are theoretically possible:
Fenfluramine.
(II) This paragraph (c) is repealed upon removal of fenfluramine and its salts and
isomers from schedule IV of the federal "Controlled Substances Act" (21 U.S.C. sec. 812; 21
CFR 1308.14).
(d) Any material, compound, mixture, or preparation containing any quantity of the
following substances having a stimulant effect on the central nervous system, including their
salts, isomers, and salts of isomers:
(I) Cathine;
(II) Diethylpropion;
(III) Fencamfamin;
(IV) Fenpropore;
(V) Mazindol;
(VI) Pemoline (including organometallic complexes and chelates thereof);
(VII) Phentermine;
(VIII) Pipradrol;
(IX) SPA ((-)-1-dimethylamino-1,2-diphenylethane);
(e) Any material, compound, mixture, or preparation containing any quantity of the
following substances, including their salts and isomers:
(I) Modafinil;
(II) Pentazocine;
(III) Sibutramine;
(IV) Stadol (butorphanol tartrate);
(f) Zaleplon.
(3) The board may exempt by rule any compound, mixture, or preparation containing
any depressant substance listed in paragraph (b) of subsection (2) of this section from the
application of all or any part of this article if the compound, mixture, or preparation contains one
or more active medicinal ingredients not having a depressant effect on the central nervous
system, and if the admixtures are in combinations, quantity, proportion, or concentration that
vitiate the potential for abuse of the substances having a depressant effect on the central nervous
system.

‹ Prev All Colorado sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.